Skip to main content
Clinical Trials/CTRI/2022/10/046656
CTRI/2022/10/046656
Not yet recruiting
未知

Prevalence of Metabolic Syndrome (MetS) in patients with clinical syndrome of Heart Failure with preserved Ejection Fraction (HFpEF) using H2FPEF score in a tertiary care hospital in South India-A cross sectional study

KMC, Manipal0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
KMC, Manipal
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
KMC, Manipal

Eligibility Criteria

Inclusion Criteria

  • Adults Male and Females 18 years of age or more presenting with the clinical syndrome of heart failure and LVEF more than equal to 50% to the medicine or cardiology or emergency medicine departments of the hospital. Clinical syndrome of HFpEF will be defined according to the Framingham criteria or H2FpEF score

Exclusion Criteria

  • 1\. Cardiac Amyloidosis
  • 2\. Restrictive Cardiomyopathy
  • 3\. Hypertrophic Cardiomyopathy
  • 4\. Valvular Heart Disease (Moderate to severe Stenosis or Regurgitation)
  • 5\. Right Heart Failure (RV infarction, ARVC)
  • 6\. Pericardial Disease (Cardiac tamponade, Constrictive Pericarditis)
  • 7\. Obstructive Lesions in heart or great vessels (Atrial Myxoma, Pulmonary valve stenosis)

Outcomes

Primary Outcomes

Not specified

Similar Trials